| Original language | English |
|---|---|
| Pages (from-to) | 5-7 |
| Number of pages | 3 |
| Journal | Immunological Reviews |
| Volume | 280 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Nov 2017 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Immunological Reviews, Vol. 280, No. 1, 01.11.2017, p. 5-7.
Research output: Contribution to journal › Editorial
TY - JOUR
T1 - Death, danger & immunity
T2 - Fundamental mechanisms linking pathogenic or iatrogenic cell death events to immune responses
AU - Kroemer, Guido
N1 - Funding Information: Agence Nationale de la Recherche; Institut National Du Cancer; Fondation pour la Recherche Médicale; ACG Institute for Clinical Research and Education; European Research Council; Ligue contre le Cancer Comité de Charente-Maritime (équipe labelisée); Agence National de la Recherche (ANR) – Projets blancs; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche Médicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumière: the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); the Paris Alliance of Cancer Research Institutes (PACRI) Funding Information: This work was supported by the Ligue contre le Cancer Comité de Charente-Maritime (équipe labelisée); Agence National de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche Médicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumière: the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).
PY - 2017/11/1
Y1 - 2017/11/1
UR - http://www.scopus.com/inward/record.url?scp=85031127810&partnerID=8YFLogxK
U2 - 10.1111/imr.12604
DO - 10.1111/imr.12604
M3 - Editorial
C2 - 29027215
AN - SCOPUS:85031127810
SN - 0105-2896
VL - 280
SP - 5
EP - 7
JO - Immunological Reviews
JF - Immunological Reviews
IS - 1
ER -